News

SEATTLE, Wash and VANCOUVER, British Columbia, May 9, 2018 — Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced first quarter 2018 financial results and recent highlights. First-Quarter 2018 Highlights. Announced preliminary results from a Phase I/II clinical study evaluating…

BOTHELL, Wash and VANCOUVER, British Columbia, March 1, 2018 — Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today highlighted recent accomplishments and announced fourth quarter and year-end 2017 financial results. Recent Highlights. Announced preliminary results from clinical study evaluating pharmacokinetic…

BOTHELL, Wash and VANCOUVER, British Columbia, November 8, 2017 — Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that Rick Stewart, Chairman and Chief Executive Officer, will present at the 29th Annual Piper Jaffray Healthcare Conference being held on…

BOTHELL, Wash and VANCOUVER, British Columbia, November 6, 2017 – Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that the November 2nd presentation given by Rick Stewart, Chairman and Chief Executive Officer, is now available for on-demand viewing at…

Company invites individual and institutional investors and advisors to attend virtualinvestorconferences.com. BOTHELL, Wash and VANCOUVER, British Columbia, Oct. 30, 2017 – Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that Rick Stewart, Chairman and Chief Executive Officer, will be…